The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Could the posting of an intraday RNS specifying the number of shares possibly hint towards a re-rate? From 56 billion at £0.0002/share to 1 billion share ~£0.10/share?
Makes the same value of the company and in your pocket, but less like a bitcoin value, and more like a traded asset?
Thoughts?
Need some basic math assistance I think:
160000000 to 1% = 1600000, just remove two zeros.
1600000 * 3 = 4800000, add it up three times, or think what a treble 16 is at darts and add all the zeros back.
So 4.8 million euros in fees for the first transaction.
Proof of concept and money raising demonstrated complete. Happy days.
@SW01 the warrant allows you to buy at a fixed price, regardless of what the present market price is. So providing you don’t buy if the SP is less than the warrant strike price then it’s profit.
Or am I missing something?
I’ve just spoken to my broker and they confirm the comment that HMRC views warrants as not protected similarly to shares held within an ISA, so they have to be moved to a normal share trading account.
Everyday is a school day.
This statement should have been in bold:
As such the Directors have prudently identified uncertainty in the cash flow model. This uncertainty arises with respect to both the future timing and growth rates of the forecast cashflows arising from the Group's multiple revenue streams referred to above. In this regard, if these future revenues are not secured as the Directors envisage, it is possible that the Group will have a shortfall in cash and require additional funding during the forecast period. In addition certain cashflows in relation to the financing transactions noted above have not yet occurred and the issue of new ordinary shares under the Capital Raise Plan is subject to the authorisation from shareholders in the General Meeting. On the basis of the above, the Directors believe there are material uncertainties which may cast significant doubt upon the entities ability to continue as a going concern.
It’s only a loss when you sell, so at this point I may as well hold and hope for some form of dead cat bounce.
@pontiac, I think you’ll find otherwise. Been holding and buying for over two years now. Was only commenting on this spike in the last hour, like most of them these is no seemingly obvious justification. So, to all a good weekend, except you, go **** a hedgehog.
Got this in my inbox from an enquiry a week ago;
We are on track to publish our Annual Results for the year-ended 31 December 2021 by the end of April 2022, which will include detail on the performance of Supply@ME Group’s operating divisions. We will also share our new strategic growth plan by the end of April 2022.
Regards,
The Investor Relations team at Supply@Me